Invention Grant
- Patent Title: Aryl ether pyridazinone derivatives
- Patent Title (中): 芳基醚哒嗪酮衍生物
-
Application No.: US12602284Application Date: 2008-05-02
-
Publication No.: US08445489B2Publication Date: 2013-05-21
- Inventor: Frank Stieber , Oliver Schadt , Dieter Dorsch , Andree Blaukat
- Applicant: Frank Stieber , Oliver Schadt , Dieter Dorsch , Andree Blaukat
- Applicant Address: DE Darmstadt
- Assignee: Merck Patent GmbH
- Current Assignee: Merck Patent GmbH
- Current Assignee Address: DE Darmstadt
- Agency: Millen, White, Zelano & Branigan, P.C.
- Priority: DE102007025717 20070601
- International Application: PCT/EP2008/003549 WO 20080502
- International Announcement: WO2008/145242 WO 20081204
- Main IPC: A61K31/535
- IPC: A61K31/535 ; C07D413/12
Abstract:
Compounds of the formula I, in which R1, R2, R3, R4, R5 and X have the meanings indicated in Claim 1, are inhibitors of tyrosine kinases, in particular Met kinase, and can be employed, inter alia, for the treatment of tumors.
Public/Granted literature
- US20100179149A1 ARYL ETHER PYRIDAZINONE DERIVATIVES Public/Granted day:2010-07-15
Information query
